Telemedicine is Cost Effective Compared with Standard Care in Type 2 Diabetes Mellitus – A Randomized Trial with an Economic Analysis in an Outpatient Clinic

Telemedicine is Cost Effective Compared with Standard Care in Type 2 Diabetes Mellitus – A Randomized Trial with an Economic Analysis in an Outpatient Clinic

Authors Information

1 Medical Dept., Kolding Hospital, SLB
2 Gynecological Dept, Herning Hospital
3 Centre for Quality, Quality Improvement and Risk Management, Middelfart, Denmark

Article Notes and Dates

Biotechnology and Health Sciences: August 2017, 4(2); e57649.Published Online: July 13, 2017
Article Type: Research Article; Received: November 28, 2016; Revised: March 1, 2017; Accepted: March 13, 2017
DOI: http://dx.doi.org/10.5812/bhs.57649
To Cite : Rasmussen O W, Friis Lauszus F, Lokke M, Sall Jensen M. Telemedicine is Cost Effective Compared with Standard Care in Type 2 Diabetes Mellitus – A Randomized Trial with an Economic Analysis in an Outpatient Clinic, Biotech Health Sci. 2017 ;4(2):e57649. doi: 10.5812/bhs.57649.
Copyright: Copyright © 2017, Biotechnology and Health Sciences. .
Abstract
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Bower P, Cartwright M, Hirani SP, Barlow J, Hendy J, Knapp M, et al. A comprehensive evaluation of the impact of telemonitoring in patients with long-term conditions and social care needs: protocol for the whole systems demonstrator cluster randomised trial. BMC Health Serv Res. 2011; 11: 184[PubMed]
  • 2. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358(6): 580-91[PubMed]
  • 3. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2009; 32(1): 193-203
  • 4. Drivsholm TB, Snorgaard O. [Organization of treatment and control of type 2 diabetic patients]. Ugeskr Laeger. 2012; 174(37): 2159-62[PubMed]
  • 5. Vadstrup ES, Frolich A, Perrild H, Borg E, Roder M. Effect of a group-based rehabilitation programme on glycaemic control and cardiovascular risk factors in type 2 diabetes patients: the Copenhagen Type 2 Diabetes Rehabilitation Project. Patient Educ Couns. 2011; 84(2): 185-90[PubMed]
  • 6. Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring JE, et al. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001; 161(2): 242-7[PubMed]
  • 7. Zhou P, Xu L, Liu X, Huang J, Xu W, Chen W. Web-based telemedicine for management of type 2 diabetes through glucose uploads: a randomized controlled trial. Int J Clin Exp Pathol. 2014; 7(12): 8848-54[PubMed]
  • 8. Wootton R. Twenty years of telemedicine in chronic disease management–an evidence synthesis. J Telemed Telecare. 2012; 18(4): 211-20[PubMed]
  • 9. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359(15): 1577-89[PubMed]
  • 10. Goudswaard AN, Stolk RP, Zuithoff NP, de Valk HW, Rutten GE. Long-term effects of self-management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care. Diabet Med. 2004; 21(5): 491-6[PubMed]
  • 11. Mitra A, Dewanjee D, Dey B. Mechanistic studies of lifestyle interventions in type 2 diabetes. World J Diabetes. 2012; 3(12): 201-7[PubMed]
  • 12. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002; 25(7): 1159-71[PubMed]
  • 13. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006; 166(17): 1836-41[PubMed]
  • 14. Shea S, Weinstock RS, Teresi JA, Palmas W, Starren J, Cimino JJ, et al. A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus: 5 Year Results of the IDEATel Study. J Am Med Inf Assoc. 2009; 16(4): 446-56[DOI]
  • 15. Stone RA, Rao RH, Sevick MA, Cheng C, Hough LJ, Macpherson DS, et al. Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial. Diabetes Care. 2010; 33(3): 478-84[PubMed]
  • 16. Hailey D, Ohinmaa A, Roine R. Study quality and evidence of benefit in recent assessments of telemedicine. J Telemed Telecare. 2004; 10(6): 318-24[PubMed]
  • 17. Durrani H, Khoja S. A systematic review of the use of telehealth in Asian countries. J Telemed Telecare. 2009; 15(4): 175-81[PubMed]
  • 18. Hendy J, Chrysanthaki T, Barlow J, Knapp M, Rogers A, Sanders C, et al. An organisational analysis of the implementation of telecare and telehealth: the whole systems demonstrator. BMC Health Serv Res. 2012; 12: 403[PubMed]
  • 19. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, et al. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ. 2012; 344[PubMed]
  • 20. Cartwright M, Hirani SP, Rixon L, Beynon M, Doll H, Bower P, et al. Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial. BMJ. 2013; 346[DOI]
  • 21. Sanders C, Rogers A, Bowen R, Bower P, Hirani S, Cartwright M, et al. Exploring barriers to participation and adoption of telehealth and telecare within the Whole System Demonstrator trial: a qualitative study. BMC Health Serv Res. 2012; 12: 220[PubMed]
  • 22. Montori VM, Gafni A, Charles C. A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect. 2006; 9(1): 25-36[DOI]
  • 23. van Dam HA, van der Horst F, van den Borne B, Ryckman R, Crebolder H. Provider-patient interaction in diabetes care: effects on patient self-care and outcomes. A systematic review. Patient Educ Couns. 2003; 51(1): 17-28[PubMed]
  • 24. Michie S, Miles J, Weinman J. Patient-centredness in chronic illness: what is it and does it matter? Patient Educ Couns. 2003; 51(3): 197-206[PubMed]
  • 25. Charles C, Whelan T, Gafni A. What do we mean by partnership in making decisions about treatment? BMJ. 1999; 319(7212): 780-2[PubMed]